Ignite Creation Date:
2024-05-06 @ 11:07 AM
Last Modification Date:
2024-10-26 @ 12:40 PM
Study NCT ID:
NCT03439358
Status:
SUSPENDED
Last Update Posted:
2021-02-26
First Post:
2018-02-07
Brief Title:
Magnesium for Shivering in Epidural Lidocaine Deliveries
Sponsor:
University of British Columbia
Organization:
University of British Columbia
Study Overview
Official Title:
Intravenous Magnesium Sulfate for the Prevention of Intraoperative Shivering in Parturients Undergoing Cesarean Delivery Under Lidocaine Top-up Via a Pre-existing Epidural Catheter Inserted for Labor Analgesia - A Randomized Double-blind Placebo-controlled Trial
Status:
SUSPENDED
Status Verified Date:
2021-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Could not recruit patients
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Mag-SHIELD
Brief Summary:
Magnesium has been shown to decrease the shivering experienced from neuraxial anesthesia This study aims to investigate whether magnesium decreases the shivering experienced in parturients undergoing labor epidural anesthesia for Cesarean delivery
Detailed Description:
Women who have epidurals in place and go on to require a Cesarean delivery typically have their epidurals topped-up with a fast onset local anesthetic to ensure the lower body is fully numb for surgery This is called an epidural top-up However a side effect of epidural top-ups is shivering which is uncomfortable for the mother and interferes with patient monitoring Magnesium administration has been shown to decrease shivering in the non-pregnant population Therefore in this study the investigators aim to determine if magnesium given prior to an epidural top-up decreases the incidence and severity of shivering in the pregnant population
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None